Optum Ventures, the venture capital arm of Optum, is participating in a $180 million funding round for Caresyntax, a data-assisted surgery platform.
Caresyntax's platform aims to tackle the significant data gaps and fragmentation that have stalled the advancement of precision surgery, according to an Aug. 15 news release. The company will use the funding to fast-track the adoption and development of its AI-powered surgical software and support strategic mergers and acquisitions.
Caresyntax's software is used by more than 30,000 surgical professionals, according to the release.